🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11599+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11599 recruiting trials

NARecruitingNCT06926127

Genomic Profiling of Genetic and Rare Diseases

👨‍⚕️ Giovanni Scambia, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06615492

Routine vs On-demand ECMO for Lung Transplantation

🏥 Centre hospitalier de l'Université de Montréal (CHUM)📍 4 sites📅 Started Nov 2024View details ↗
RecruitingNCT06886282

Spatial RadiomIcs and TRanscriptomics to the DIscovery of the Cross-link Between Colon Cancer and ChrOnic Kidney Disease

🏥 National Cancer Institute, Naples📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06266403

Evaluating Verbal Communication in Structured Interactions: Theoretical and Clinical Implications

👨‍⚕️ Jimin Lee, PhD, The Pennsylvania State University📍 1 site📅 Started Nov 2024View details ↗
Phase 1, PHASE2RecruitingNCT06488924

An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB

🏥 JCR Pharmaceuticals Co., Ltd.📍 3 sites📅 Started Nov 2024View details ↗
Enrolling by InvitationNCT06703801

Evaluation of the Progression of Disease and Health-related Quality of Life in Patients With Pulmonary Hypertension: A Local Clinic-based Registry

🏥 Chinese University of Hong Kong📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06578104

PULSED AF Post-Approval Study

👨‍⚕️ Khaldoun Tarakji, MD, Medtronic CAS Chief Medical Officer📍 16 sites📅 Started Nov 2024View details ↗
RecruitingNCT07043491

Comparison of Endoscopy and Esophagram for the Routine Evaluation of Anastomosis After McKeown Esophagectomy

👨‍⚕️ Hong Yang, PhD., Sun Yat-sen University📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06488313

A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD

🏥 Arcturus Therapeutics, Inc.📍 1 site📅 Started Nov 2024View details ↗
RecruitingNCT07036874

Non-invasive Assessment for Outcome Prediction in Patients With Hepatocellular Carcinoma

👨‍⚕️ Jimmy CT Lai, MB ChB, Chinese University of Hong Kong📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06523361

Contribution of Immersive Virtual Reality to a Standardized Rehabilitation Program for Upper Limb Chronic Pain: A Single-Case Experimental Design Study

🏥 University Hospital, Angers📍 2 sites📅 Started Nov 2024View details ↗
RecruitingNCT06298565

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

🏥 argenx📍 35 sites📅 Started Nov 2024View details ↗
RecruitingNCT06636383

Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program

👨‍⚕️ Medical Director, Ultragenyx Pharmaceuticals Inc.📍 19 sites📅 Started Nov 2024View details ↗
Phase 1, PHASE2RecruitingNCT06733935

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

👨‍⚕️ Nkarta Study Director, Nkarta, Inc.📍 14 sites📅 Started Nov 2024View details ↗
RecruitingNCT06645899

Institution of an Italian Multicenter Database of Patients Affected by Hypoparathyroidism or Pseudohypoparathyroidism

🏥 F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore📍 41 sites📅 Started Nov 2024View details ↗
NARecruitingNCT06614777

Characterization of the Cytokine Profile and the Microbiome in Darier's Disease

👨‍⚕️ Juliette Mazereeuw-hautier, MD, University Hospital of Toulouse📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06121180

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

👨‍⚕️ Ahmad Tarhini, MD, PHD, Moffitt Cancer Center📍 4 sites📅 Started Nov 2024View details ↗
NARecruitingNCT06668649

Polish Version Fatigue Severity Scale

👨‍⚕️ Jakub M Antczak, MD, Jagiellonian University📍 2 sites📅 Started Nov 2024View details ↗
NARecruitingNCT06645951

Institution of an Italian Multicenter Database of Patients with Parathyroid Carcinoma or Atypical Parathyroid Adenoma

👨‍⚕️ Maria Luisa Brandi, MD, PhD📍 20 sites📅 Started Nov 2024View details ↗
Phase 1, PHASE2Enrolling by InvitationNCT06762431

Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.

🏥 Vitebsk Regional Clinical Cancer Centre📍 1 site📅 Started Nov 2024View details ↗
← PreviousPage 210 of 580Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →